| 1B1C | A:7-172 | CRYSTAL STRUCTURE OF THE FMN-BINDING DOMAIN OF HUMAN CYTOCHROME P450 REDUCTASE AT 1.93A RESOLUTION |
| 1D4A | A:1-273; B:1-273; C:1-273; D:1-273 | CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE AT 1.7 A RESOLUTION |
| 1DXO | A:1-273; B:1-273; C:1-273; D:1-273 | CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2,3, 5,6,TETRAMETHYL-P-BENZOQUINONE (DUROQUINONE) AT 2.5 ANGSTROM RESOLUTION |
| 1GG5 | A:1-273; B:1-273; C:1-273; D:1-273 | CRYSTAL STRUCTURE OF A COMPLEX OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE AND A CHEMOTHERAPEUTIC DRUG (E09) AT 2.5 A RESOLUTION |
| 1H66 | A:1-273; B:1-273; C:1-273; D:1-273 | CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2,5-DIAZIRIDINYL-3-HYDROXYL-6-METHYL-1,4-BENZOQUINONE |
| 1H69 | A:1-273; B:1-273; C:1-273; D:1-273 | CRYSTAL STRUCTURE OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE CO WITH 2,3,5,6,TETRAMETHYL-P-BENZOQUINONE (DUROQUINONE) AT 2.5 ANGSTROM RESOLUTION |
| 1KBO | A:1-273; B:1-273; C:1-273; D:1-273 | COMPLEX OF HUMAN RECOMBINANT NAD(P)H:QUINONE OXIDE REDUCTASE TYPE 1 WITH 5-METHOXY-1,2-DIMETHYL-3-(PHENOXYMETHYL)INDOLE-4,7-DIONE (ES1340) |
| 1KBQ | B:3-273; C:3-273; A:2-273; D:2-273 | COMPLEX OF HUMAN NAD(P)H QUINONE OXIDOREDUCTASE WITH 5-METHOXY-1,2-DIMETHYL-3-(4-NITROPHENOXYMETHYL)INDOLE-4,7-DIONE (ES936) |
| 1QBG | B:3-273; A:2-273; C:2-273; D:2-273 | CRYSTAL STRUCTURE OF HUMAN DT-DIAPHORASE (NAD(P)H OXIDOREDUCTASE) |
| 1QR2 | A:1-230; B:1-230 | HUMAN QUINONE REDUCTASE TYPE 2 |
| 1SG0 | A:1-230; B:1-230 | CRYSTAL STRUCTURE ANALYSIS OF QR2 IN COMPLEX WITH RESVERATROL |
| 1XI2 | A:1-230; B:1-230 | QUINONE REDUCTASE 2 IN COMPLEX WITH CANCER PRODRUG CB1954 |
| 1ZX1 | A:1-228; B:2-230 | HUMAN QUINONE OXIDOREDUCTASE 2 (NQO2) IN COMPLEX WITH THE CYTOSTATIC PRODRUG CB1954 |
| 2BZS | A:1-230; B:1-230 | BINDING OF ANTI-CANCER PRODRUG CB1954 TO THE ACTIVATING ENZYME NQO2 REVEALED BY THE CRYSTAL STRUCTURE OF THEIR COMPLEX. |
| 2F1O | A:1-273; B:1-273; C:1-273; D:1-273; E:1-273; F:1-273; G:1-273; H:1-273 | CRYSTAL STRUCTURE OF NQO1 WITH DICOUMAROL |
| 2QMY | A:1-230; B:1-230 | QUINONE REDUCTASE 2 IN COMPLEX WITH ADRENOCHROME |
| 2QMZ | A:1-230; B:1-230 | QUINONE REDUCTASE 2 IN COMPLEX WITH DOPAMINE |
| 2QR2 | A:1-230; B:1-230 | HUMAN QUINONE REDUCTASE TYPE 2, COMPLEX WITH MENADIONE |
| 2QWX | A:1-230; B:1-230 | CRYSTAL STRUCTURE OF QUINONE REDUCTASE II |
| 2QX4 | A:1-230; B:1-230 | CRYSTAL STRUCTURE OF QUINONE REDUCTASE II |
| 2QX6 | A:1-230; B:1-230 | CRYSTAL STRUCTURE OF QUINONE REDUCTASE II |
| 2QX8 | A:1-230; B:1-230 | CRYSTAL STRUCTURE OF QUINONE REDUCTASE II |
| 2QX9 | A:1-230; B:1-230 | CRYSTAL STRUCTURE OF QUINONE REDUCTASE II |
| 3FW1 | A:2-229 | QUINONE REDUCTASE 2 |
| 3G5M | A:1-230; B:1-230 | SYNTHESIS OF CASIMIROIN AND OPTIMIZATION OF ITS QUINONE REDUCTASE 2 AND AROMATASE INHIBITORY ACTIVITY |
| 3GAM | A:1-230; B:1-230 | SYNTHESIS OF CASIMIROIN AND OPTIMIZATION OF ITS QUINONE REDUCTASE 2 AND AROMATASE INHIBITORY ACTIVITY |
| 3JSX | A:2-271; B:2-271; C:2-271; D:2-271; E:2-271; F:2-271; G:2-271; H:2-271 | X-RAY CRYSTAL STRUCTURE OF NAD(P)H: QUINONE OXIDOREDUCTASE-1 (NQO1) BOUND TO THE COUMARIN-BASED INHIBITOR AS1 |
)
)